Wake up to changed EU regulatory environment, Eucomed tells medtech
This article was originally published in SRA
Executive Summary
The EU medtech environment today is a different place in which to do business compared with just a year ago. John Brennan of Eucomed told Amanda Maxwell how the medical device industry is approaching the next phase of dialog with the new decision-makers in Europe, what its priorities are, and how companies should be positioning themselves to cope with new expectations.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.